Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209176 · ClinicalTrials.gov registry record · NA
Physician- and Patient-based Barriers to NGS Testing
A NA study of Metastatic Prostate Cancer, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- Recruiting
- Registry status
- NA
- Development phase
- 256
- Enrollment target
- 1
- Study location
NCT07209176 is a NA study of Metastatic Prostate Cancer that is actively recruiting participants, run by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. The registered enrollment target is 256 participants, above the 180-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (42% higher). The trial reports 1 study location across 1 state.
The verdict
NCT07209176, a NA study of Metastatic Prostate Cancer, is actively recruiting participants, sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
- RECRUITING
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
Conditions Studied
Interventions
- OTHER Provider-level and patient education at end of study
- OTHER Provider-level and patient-level
Study Locations (1)
Maryland
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2027-09-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07209176
The ClinicalTrials.gov registry entry for NCT07209176 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 256 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 180-participant average among 41 other Metastatic Prostate Cancer trials with a reported enrollment target (42% higher). The listed sponsor is Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Metastatic Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Provider-level and patient education at end of study is the first listed.
NCT07209176 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT07209176 about?
NCT07209176 is a clinical study titled "Physician- and Patient-based Barriers to NGS Testing". The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
What is the current status of trial NCT07209176?
This trial is currently recruiting. It is a NA study. The enrollment target is 256 participants. The study started on 2026-01-06. Estimated completion is 2027-09-06.
What conditions does trial NCT07209176 study?
This clinical trial studies the following conditions: Metastatic Prostate Cancer.
What interventions are being tested in trial NCT07209176?
The interventions under investigation include: Provider-level and patient education at end of study (OTHER), Provider-level and patient-level (OTHER).
Who is sponsoring clinical trial NCT07209176?
This trial is sponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, which has 523 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209176 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
RECRUITING · NA
-
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
RECRUITING · NA
-
7-Days Water-Only Fasting Trial in Prostate Cancer
RECRUITING · NA
-
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006)
RECRUITING · NA
-
INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)
ACTIVE NOT RECRUITING · NA
-
Study of AZD0754 in Participants With Metastatic Prostate Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.